UniProt ID | MECP2_HUMAN | |
---|---|---|
UniProt AC | P51608 | |
Protein Name | Methyl-CpG-binding protein 2 | |
Gene Name | MECP2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 486 | |
Subcellular Localization | Nucleus . Colocalized with methyl-CpG in the genome. Colocalized with TBL1X to the heterochromatin foci. | |
Protein Description | Chromosomal protein that binds to methylated DNA. It can bind specifically to a single methyl-CpG pair. It is not influenced by sequences flanking the methyl-CpGs. Mediates transcriptional repression through interaction with histone deacetylase and the corepressor SIN3A. Binds both 5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC)-containing DNA, with a preference for 5-methylcytosine (5mC).. | |
Protein Sequence | MVAGMLGLREEKSEDQDLQGLKDKPLKFKKVKKDKKEEKEGKHEPVQPSAHHSAEPAEAGKAETSEGSGSAPAVPEASASPKQRRSIIRDRGPMYDDPTLPEGWTRKLKQRKSGRSAGKYDVYLINPQGKAFRSKVELIAYFEKVGDTSLDPNDFDFTVTGRGSPSRREQKPPKKPKSPKAPGTGRGRGRPKGSGTTRPKAATSEGVQVKRVLEKSPGKLLVKMPFQTSPGGKAEGGGATTSTQVMVIKRPGRKRKAEADPQAIPKKRGRKPGSVVAAAAAEAKKKAVKESSIRSVQETVLPIKKRKTRETVSIEVKEVVKPLLVSTLGEKSGKGLKTCKSPGRKSKESSPKGRSSSASSPPKKEHHHHHHHSESPKAPVPLLPPLPPPPPEPESSEDPTSPPEPQDLSSSVCKEEKMPRGGSLESDGCPKEPAKTQPAVATAATAAEKYKHRGEGERKDIVSSSMPRPNREEPVDSRTPVTERVS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
10 (in isoform 2) | Phosphorylation | - | 74.87 | 22673903 | |
13 | Phosphorylation | LGLREEKSEDQDLQG CCCCCCCCCCCCCCC | 50.08 | 26657352 | |
25 (in isoform 2) | Phosphorylation | - | 51.41 | 25849741 | |
49 | Phosphorylation | KHEPVQPSAHHSAEP CCCCCCCCCCCCCCH | 24.12 | 23927012 | |
53 | Phosphorylation | VQPSAHHSAEPAEAG CCCCCCCCCCHHHCC | 25.18 | 25849741 | |
64 | Phosphorylation | AEAGKAETSEGSGSA HHCCCCCCCCCCCCC | 36.62 | 22167270 | |
65 | Phosphorylation | EAGKAETSEGSGSAP HCCCCCCCCCCCCCC | 31.31 | 22167270 | |
68 | Phosphorylation | KAETSEGSGSAPAVP CCCCCCCCCCCCCCC | 26.06 | 22167270 | |
70 | Phosphorylation | ETSEGSGSAPAVPEA CCCCCCCCCCCCCCC | 32.54 | 22167270 | |
78 | Phosphorylation | APAVPEASASPKQRR CCCCCCCCCCHHHHH | 27.84 | 29255136 | |
80 | Phosphorylation | AVPEASASPKQRRSI CCCCCCCCHHHHHHH | 30.09 | 29255136 | |
80 (in isoform 2) | Phosphorylation | - | 30.09 | 27251275 | |
82 (in isoform 2) | Phosphorylation | - | 54.67 | 27251275 | |
86 | Phosphorylation | ASPKQRRSIIRDRGP CCHHHHHHHHHCCCC | 25.26 | 22210691 | |
90 (in isoform 2) | Phosphorylation | - | 49.86 | 21406692 | |
92 (in isoform 2) | Phosphorylation | - | 18.67 | 24719451 | |
95 | Phosphorylation | IRDRGPMYDDPTLPE HHCCCCCCCCCCCCC | 21.96 | 28509920 | |
98 (in isoform 2) | Phosphorylation | - | 32.70 | 24719451 | |
115 | Methylation | LKQRKSGRSAGKYDV HHHHCCCCCCCCEEE | 30.35 | 115385825 | |
116 | Phosphorylation | KQRKSGRSAGKYDVY HHHCCCCCCCCEEEE | 44.92 | 18669648 | |
119 | "N6,N6-dimethyllysine" | KSGRSAGKYDVYLIN CCCCCCCCEEEEEEC | 37.68 | - | |
119 | Methylation | KSGRSAGKYDVYLIN CCCCCCCCEEEEEEC | 37.68 | - | |
120 | Phosphorylation | SGRSAGKYDVYLINP CCCCCCCEEEEEECC | 15.10 | 18669648 | |
123 | Phosphorylation | SAGKYDVYLINPQGK CCCCEEEEEECCCCH | 10.04 | 29759185 | |
130 | Ubiquitination | YLINPQGKAFRSKVE EEECCCCHHHHHHHH | 38.82 | 2189047 | |
130 (in isoform 1) | Ubiquitination | - | 38.82 | 21890473 | |
142 (in isoform 2) | Ubiquitination | - | 5.60 | 21890473 | |
148 | Phosphorylation | YFEKVGDTSLDPNDF EEEECCCCCCCCCCC | 25.84 | 30108239 | |
149 | Phosphorylation | FEKVGDTSLDPNDFD EEECCCCCCCCCCCC | 35.20 | 25159151 | |
158 | Phosphorylation | DPNDFDFTVTGRGSP CCCCCCCEECCCCCC | 20.99 | 23401153 | |
160 | Phosphorylation | NDFDFTVTGRGSPSR CCCCCEECCCCCCCC | 20.36 | 23401153 | |
161 (in isoform 2) | Phosphorylation | - | 27.84 | 24719451 | |
162 | Methylation | FDFTVTGRGSPSRRE CCCEECCCCCCCCCC | 32.81 | 30988067 | |
164 | Phosphorylation | FTVTGRGSPSRREQK CEECCCCCCCCCCCC | 20.52 | 25159151 | |
166 | Phosphorylation | VTGRGSPSRREQKPP ECCCCCCCCCCCCCC | 45.74 | 25159151 | |
172 (in isoform 2) | Phosphorylation | - | 45.71 | 27251275 | |
176 (in isoform 2) | Phosphorylation | - | 48.78 | 21406692 | |
178 | Phosphorylation | KPPKKPKSPKAPGTG CCCCCCCCCCCCCCC | 39.91 | 30576142 | |
178 (in isoform 2) | Phosphorylation | - | 39.91 | 24719451 | |
184 | Phosphorylation | KSPKAPGTGRGRGRP CCCCCCCCCCCCCCC | 23.73 | 24719451 | |
196 (in isoform 2) | Phosphorylation | - | 22.71 | 24719451 | |
203 | Phosphorylation | TTRPKAATSEGVQVK CCCCCCCCCCCCEEE | 31.97 | 27362937 | |
204 | Phosphorylation | TRPKAATSEGVQVKR CCCCCCCCCCCEEEE | 27.85 | 27362937 | |
210 | "N6,N6-dimethyllysine" | TSEGVQVKRVLEKSP CCCCCEEEEHHHCCC | 21.50 | - | |
210 | 2-Hydroxyisobutyrylation | TSEGVQVKRVLEKSP CCCCCEEEEHHHCCC | 21.50 | - | |
210 | Acetylation | TSEGVQVKRVLEKSP CCCCCEEEEHHHCCC | 21.50 | 25953088 | |
210 | Methylation | TSEGVQVKRVLEKSP CCCCCEEEEHHHCCC | 21.50 | - | |
216 | Phosphorylation | VKRVLEKSPGKLLVK EEEHHHCCCCCEEEE | 29.52 | 23401153 | |
219 | Acetylation | VLEKSPGKLLVKMPF HHHCCCCCEEEECCE | 41.87 | 25953088 | |
223 | Ubiquitination | SPGKLLVKMPFQTSP CCCCEEEECCEECCC | 40.60 | - | |
228 | Phosphorylation | LVKMPFQTSPGGKAE EEECCEECCCCCCCC | 36.95 | 30266825 | |
228 (in isoform 2) | Phosphorylation | - | 36.95 | 24719451 | |
229 | Phosphorylation | VKMPFQTSPGGKAEG EECCEECCCCCCCCC | 15.68 | 29255136 | |
240 (in isoform 2) | Phosphorylation | - | 25.26 | 24719451 | |
241 (in isoform 2) | Phosphorylation | - | 29.28 | 21406692 | |
246 | Sulfoxidation | ATTSTQVMVIKRPGR CCCCCEEEEECCCCC | 1.53 | 21406390 | |
267 | Methylation | DPQAIPKKRGRKPGS CCCCCCCCCCCCCCH | 55.52 | 116252399 | |
274 | Phosphorylation | KRGRKPGSVVAAAAA CCCCCCCHHHHHHHH | 23.19 | 24972180 | |
285 | Acetylation | AAAAEAKKKAVKESS HHHHHHHHHHHHHHH | 53.68 | 30590361 | |
286 (in isoform 2) | Phosphorylation | - | 58.67 | 24719451 | |
291 | Phosphorylation | KKKAVKESSIRSVQE HHHHHHHHHHCHHHH | 25.91 | 29970186 | |
292 | Phosphorylation | KKAVKESSIRSVQET HHHHHHHHHCHHHHH | 24.10 | 29970186 | |
295 | Phosphorylation | VKESSIRSVQETVLP HHHHHHCHHHHHEEC | 26.87 | 27499020 | |
304 | Acetylation | QETVLPIKKRKTRET HHHEECCCCCCCCCE | 44.58 | 25953088 | |
311 | Phosphorylation | KKRKTRETVSIEVKE CCCCCCCEEEEEHHH | 19.09 | 26657352 | |
313 | Phosphorylation | RKTRETVSIEVKEVV CCCCCEEEEEHHHHH | 22.05 | 26657352 | |
321 | Acetylation | IEVKEVVKPLLVSTL EEHHHHHHHHHHHCC | 34.81 | 23236377 | |
323 (in isoform 2) | Phosphorylation | - | 6.46 | 24719451 | |
325 (in isoform 2) | Phosphorylation | - | 5.60 | 27251275 | |
326 | Phosphorylation | VVKPLLVSTLGEKSG HHHHHHHHCCCCCCC | 20.20 | 23312004 | |
327 | Phosphorylation | VKPLLVSTLGEKSGK HHHHHHHCCCCCCCC | 31.16 | 23312004 | |
331 | Acetylation | LVSTLGEKSGKGLKT HHHCCCCCCCCCCCC | 63.81 | 25953088 | |
332 | Phosphorylation | VSTLGEKSGKGLKTC HHCCCCCCCCCCCCC | 41.24 | 21712546 | |
347 | Methylation | KSPGRKSKESSPKGR CCCCCCCCCCCCCCC | 65.73 | 116054211 | |
349 | Phosphorylation | PGRKSKESSPKGRSS CCCCCCCCCCCCCCC | 56.53 | 23312004 | |
350 | Phosphorylation | GRKSKESSPKGRSSS CCCCCCCCCCCCCCC | 31.55 | 23312004 | |
355 | Phosphorylation | ESSPKGRSSSASSPP CCCCCCCCCCCCCCC | 37.00 | 23403867 | |
356 | Acetylation | SSPKGRSSSASSPPK CCCCCCCCCCCCCCC | 28.67 | 19608861 | |
356 | Phosphorylation | SSPKGRSSSASSPPK CCCCCCCCCCCCCCC | 28.67 | 28985074 | |
357 | Phosphorylation | SPKGRSSSASSPPKK CCCCCCCCCCCCCCC | 33.16 | 25849741 | |
359 | Phosphorylation | KGRSSSASSPPKKEH CCCCCCCCCCCCCCC | 45.38 | 24972180 | |
360 | Phosphorylation | GRSSSASSPPKKEHH CCCCCCCCCCCCCCC | 44.96 | 24972180 | |
371 (in isoform 2) | Phosphorylation | - | 23.08 | 27251275 | |
395 | Phosphorylation | PPPPEPESSEDPTSP CCCCCCCCCCCCCCC | 50.14 | 26657352 | |
396 | Phosphorylation | PPPEPESSEDPTSPP CCCCCCCCCCCCCCC | 44.34 | 26657352 | |
400 | Phosphorylation | PESSEDPTSPPEPQD CCCCCCCCCCCCCCC | 67.21 | 30278072 | |
401 | Phosphorylation | ESSEDPTSPPEPQDL CCCCCCCCCCCCCCC | 43.79 | 26657352 | |
409 | Phosphorylation | PPEPQDLSSSVCKEE CCCCCCCCCHHCCCC | 28.93 | 30278072 | |
410 | Phosphorylation | PEPQDLSSSVCKEEK CCCCCCCCHHCCCCC | 33.80 | 26657352 | |
411 | Phosphorylation | EPQDLSSSVCKEEKM CCCCCCCHHCCCCCC | 28.32 | 30177828 | |
413 (in isoform 2) | Phosphorylation | - | 5.05 | 27251275 | |
423 | Phosphorylation | EKMPRGGSLESDGCP CCCCCCCCCCCCCCC | 31.61 | 23401153 | |
426 | O-linked_Glycosylation | PRGGSLESDGCPKEP CCCCCCCCCCCCCCC | 44.59 | 30379171 | |
426 | Phosphorylation | PRGGSLESDGCPKEP CCCCCCCCCCCCCCC | 44.59 | 23401153 | |
431 | Acetylation | LESDGCPKEPAKTQP CCCCCCCCCCCCCCC | 79.14 | 27452117 | |
435 (in isoform 2) | Phosphorylation | - | 59.41 | 24719451 | |
436 | O-linked_Glycosylation | CPKEPAKTQPAVATA CCCCCCCCCCHHHHH | 41.72 | 30379171 | |
436 | Phosphorylation | CPKEPAKTQPAVATA CCCCCCCCCCHHHHH | 41.72 | 23312004 | |
442 | Phosphorylation | KTQPAVATAATAAEK CCCCHHHHHHHHHHH | 15.38 | 23312004 | |
445 | Phosphorylation | PAVATAATAAEKYKH CHHHHHHHHHHHHCC | 24.76 | 23312004 | |
449 | Acetylation | TAATAAEKYKHRGEG HHHHHHHHHCCCCCC | 55.67 | 19608861 | |
449 | Malonylation | TAATAAEKYKHRGEG HHHHHHHHHCCCCCC | 55.67 | 26320211 | |
450 | Phosphorylation | AATAAEKYKHRGEGE HHHHHHHHCCCCCCC | 11.97 | 23312004 | |
463 | Phosphorylation | GERKDIVSSSMPRPN CCCCCCCCCCCCCCC | 19.61 | 28555341 | |
465 | Phosphorylation | RKDIVSSSMPRPNRE CCCCCCCCCCCCCCC | 25.87 | 25159151 | |
477 | Phosphorylation | NREEPVDSRTPVTER CCCCCCCCCCCCCCC | 37.98 | 29255136 | |
479 | Phosphorylation | EEPVDSRTPVTERVS CCCCCCCCCCCCCCC | 26.51 | 29255136 | |
482 | Phosphorylation | VDSRTPVTERVS--- CCCCCCCCCCCC--- | 21.19 | 28348404 | |
486 | Phosphorylation | TPVTERVS------- CCCCCCCC------- | 40.50 | 28857561 | |
491 (in isoform 2) | Phosphorylation | - | 24719451 | ||
498 (in isoform 2) | Phosphorylation | - | 24719451 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
80 | S | Phosphorylation | Kinase | HIPK1 | Q86Z02 | PSP |
80 | S | Phosphorylation | Kinase | HIPK2 | Q9H2X6 | PSP |
80 | S | Phosphorylation | Kinase | HIPK2 | Q9QZR5 | PSP |
216 | S | Phosphorylation | Kinase | HIPK1 | Q86Z02 | PSP |
216 | S | Phosphorylation | Kinase | HIPK2 | Q9H2X6 | PSP |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
423 | S | Phosphorylation |
| - |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of MECP2_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
105830 | Angelman syndrome (AS) | |||||
300055 | Mental retardation, X-linked, syndromic, 13 (MRXS13) | |||||
312750 | Rett syndrome (RTT) | |||||
300496 | Autism, X-linked 3 (AUTSX3) | |||||
300673 | Encephalopathy, neonatal severe, due to MECP2 mutations (ENS-MECP2) | |||||
300260 | Mental retardation, X-linked, syndromic, Lubs type (MRXSL) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-449, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-80, AND MASSSPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-80, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-80; SER-116 AND SER-426,AND MASS SPECTROMETRY. | |
"Phosphorylation analysis of primary human T lymphocytes usingsequential IMAC and titanium oxide enrichment."; Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.; J. Proteome Res. 7:5167-5176(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-80, AND MASSSPECTROMETRY. | |
"Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-80, AND MASSSPECTROMETRY. |